Clinical trial Recruiting at 1 site Interventional Ages 50 to 80

TaVNS with gait training for newly diagnosed Parkinson’s patients

Official title: Association of VAgus Nerve Stimulation and Treadmill Training for GAit Rehabilitation in DE Novo Parkinson's Disease (AVANTGARDE-PD)

Run by Fondazione Policlinico Universitario Campus Bio-Medico · NCT07337226 · Data updated 2026-11-12

This trial tests whether using noninvasive taVNS during treadmill-based gait therapy helps people with a recent Parkinson’s diagnosis walk better and show brain changes.

More Parkinson's Disease (PD) trials

Quick facts

Study typeInterventional
Ages50 Years to 80 Years
SexAll
Enrollment60 (estimated)
SponsorFondazione Policlinico Universitario Campus Bio-Medico
Academic / other
Locations1 site (Roma, RM)
StatusRecruiting
StartedFebruary 14, 2026
Main results expectedOctober 2027
Study endsOctober 2027
Registry record updatedJuly 16, 2026
Trial IDNCT07337226 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 50–80 with a recent idiopathic PD diagnosis (≤6 months), able to walk 10 meters unaided, and stable on therapy for at least one month.

Probably not a fit

Individuals with longer-standing PD, significant cognitive impairment, or contraindications to taVNS or MRI may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, double-blind study compares active taVNS to sham stimulation during four weeks of gait-focused rehabilitation in people with idiopathic Parkinson’s disease diagnosed within the last six months. Participants receive either taVNS with conventional physical therapy or sham taVNS during each of 12 sessions, with additional assessment of gait, brain activity, and inflammatory markers. The study also examines whether taVNS paired with therapy enhances neural plasticity and movement-related brain perfusion. Outcomes are measured at baseline, immediately after the four-week program, and at a four-week follow-up. Four parallel arms evaluate the separate and combined effects of taVNS and treadmill-based training.

Why it matters

Potential benefit: If successful, taVNS paired with gait training could improve walking speed and stability and may modulate brain activity related to movement.

How similar studies have gone: Prior work suggests taVNS can influence gait and inflammatory markers in PD, supporting advancement but with mixed replication.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Idiopathic PD diagnosis within 6 months, confirmed by neurologist specialized in Parkinson's disease and movement disorders;
* Ability to walking independently for at least 10 meters unassisted;
* Age included between 50 and 80;
* MMSE \> 24;
* On stable therapy for at least 1 month prior to the experiment.

Exclusion Criteria:

* Clinical and radiological red flags for atypical, vascular parkinsonism or alternative diagnosis (e.g., normal pressure hydrocephalus);
* Levodopa equivalent daily dose \> 300 mg;
* Any contraindication for taVNS (e.g., ear lesions, auditory prosthesis)
* Any contraindication for MRI (e.g., non compatible pacemakers or prosthesis, claustrophobic subjects);
* Concomitant neurological, orthopedic or active medical/oncological condition that would affect participating to the study;
* Attempting to other neurorehabilitation programs within 3 months.

Where it's running

  • Campus Biomedico
    Roma, Rm, Italy
    Recruiting

Study contacts

  • Principal investigator: Massimo Marano, MD, PhD — Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, 00128 Roma, Italy
  • Study coordinator: Massimo Marano, MD, PhD
  • Email: m.marano@policlinicocampus.it
  • Phone: +39 3333488802

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.